Connect Biopharma (CNTB) News Today → The Crypto 9-5 Escape Plan (From Crypto 101 Media) (Ad) Free CNTB Stock Alerts $1.95 +0.50 (+34.48%) (As of 05:43 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 11 at 5:14 PM | marketbeat.comConnect Biopharma Holdings Limited (NASDAQ:CNTB) Short Interest UpdateConnect Biopharma Holdings Limited (NASDAQ:CNTB - Get Free Report) was the recipient of a large drop in short interest in the month of April. As of April 30th, there was short interest totalling 31,200 shares, a drop of 62.5% from the April 15th total of 83,100 shares. Approximately 0.1% of the shares of the stock are sold short. Based on an average daily volume of 159,800 shares, the short-interest ratio is currently 0.2 days.May 7, 2024 | globenewswire.comConnect Biopharma to Present a Late-Breaking Abstract at the American Thoracic Society (ATS) 2024 International Conference on the Positive Results from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe AsthmaApril 26, 2024 | finance.yahoo.comConnect Biopharma Holdings Limited (CNTB)April 24, 2024 | marketbeat.comBML Capital Management LLC Makes New $2.43 Million Investment in Connect Biopharma Holdings Limited (NASDAQ:CNTB)BML Capital Management LLC acquired a new position in Connect Biopharma Holdings Limited (NASDAQ:CNTB - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 2,061,438 shares of the company's stoApril 19, 2024 | marketbeat.comHC Wainwright Analysts Lift Earnings Estimates for Connect Biopharma Holdings Limited (NASDAQ:CNTB)Connect Biopharma Holdings Limited (NASDAQ:CNTB - Free Report) - Equities researchers at HC Wainwright boosted their FY2024 earnings estimates for shares of Connect Biopharma in a note issued to investors on Wednesday, April 17th. HC Wainwright analyst E. Bodnar now anticipates that the company wApril 17, 2024 | marketbeat.comConnect Biopharma (NASDAQ:CNTB) Given New $8.00 Price Target at HC WainwrightHC Wainwright raised their price target on Connect Biopharma from $7.00 to $8.00 and gave the company a "buy" rating in a research report on Wednesday.April 17, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: BioNTech SE (BNTX), Connect Biopharma Holdings (CNTB)April 17, 2024 | marketbeat.comConnect Biopharma Holdings Limited (NASDAQ:CNTB) Short Interest Up 7.5% in MarchConnect Biopharma Holdings Limited (NASDAQ:CNTB - Get Free Report) was the target of a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 115,500 shares, a growth of 7.5% from the March 15th total of 107,400 shares. Approximately 0.2% of the company's shares are short sold. Based on an average daily volume of 158,600 shares, the short-interest ratio is presently 0.7 days.April 16, 2024 | globenewswire.comConnect Biopharma Reports Full Year 2023 Financial Results and Provides Business UpdateApril 12, 2024 | marketbeat.comFY2025 EPS Estimates for Connect Biopharma Holdings Limited (NASDAQ:CNTB) Lifted by Leerink PartnrsConnect Biopharma Holdings Limited (NASDAQ:CNTB - Free Report) - Analysts at Leerink Partnrs boosted their FY2025 earnings per share estimates for Connect Biopharma in a research note issued to investors on Tuesday, April 9th. Leerink Partnrs analyst T. Smith now forecasts that the company will pApril 11, 2024 | markets.businessinsider.comBuy Rating Reaffirmed for Connect Biopharma Holdings Amid Promising Clinical Trials and Strategic PartnershipsApril 7, 2024 | marketwatch.comADRs Advance; Connect Biopharma Climbs 19%April 1, 2024 | marketwatch.comADRs End Higher; Connect Biopharma Climbs 26%March 30, 2024 | marketbeat.comConnect Biopharma Holdings Limited (NASDAQ:CNTB) Short Interest Down 13.2% in MarchConnect Biopharma Holdings Limited (NASDAQ:CNTB - Get Free Report) was the recipient of a significant decline in short interest in March. As of March 15th, there was short interest totalling 107,400 shares, a decline of 13.2% from the February 29th total of 123,700 shares. Approximately 0.2% of the company's stock are sold short. Based on an average daily trading volume, of 133,300 shares, the days-to-cover ratio is currently 0.8 days.March 19, 2024 | tmcnet.comConnect Biopharma to Participate in H.C. Wainwright 2n? Annual Autoimmune & Inflammatory Disease Virtual ConferenceMarch 19, 2024 | globenewswire.comConnect Biopharma to Participate in H.C. Wainwright 2ⁿᵈ Annual Autoimmune & Inflammatory Disease Virtual ConferenceMarch 6, 2024 | marketbeat.comEquities Analysts Issue Forecasts for Connect Biopharma Holdings Limited's FY2023 Earnings (NASDAQ:CNTB)Connect Biopharma Holdings Limited (NASDAQ:CNTB - Free Report) - HC Wainwright issued their FY2023 earnings estimates for shares of Connect Biopharma in a note issued to investors on Monday, March 4th. HC Wainwright analyst E. Bodnar forecasts that the company will earn ($0.70) per share for theMarch 5, 2024 | msn.comHC Wainwright & Co. Initiates Coverage of Connect Biopharma Holdings Limited - Depositary Receipt () (CNTB) with Buy RecommendationMarch 4, 2024 | marketbeat.comConnect Biopharma (NASDAQ:CNTB) Earns Buy Rating from Analysts at HC WainwrightHC Wainwright began coverage on shares of Connect Biopharma in a report on Monday. They set a "buy" rating and a $7.00 price target for the company.February 22, 2024 | benzinga.comConnect Biopharma Hldgs Stock (NASDAQ:CNTB) Dividends: History, Yield and DatesFebruary 12, 2024 | finance.yahoo.comConnect Biopharma Appoints Industry Veteran James Huang to Board of DirectorsFebruary 8, 2024 | marketbeat.comFY2024 EPS Estimates for Connect Biopharma Holdings Limited Lowered by Analyst (NASDAQ:CNTB)Connect Biopharma Holdings Limited (NASDAQ:CNTB - Free Report) - Investment analysts at Leerink Partnrs dropped their FY2024 earnings per share estimates for Connect Biopharma in a report issued on Monday, February 5th. Leerink Partnrs analyst T. Smith now anticipates that the company will post eFebruary 7, 2024 | marketbeat.comLeerink Partnrs Comments on Connect Biopharma Holdings Limited's FY2028 Earnings (NASDAQ:CNTB)Connect Biopharma Holdings Limited (NASDAQ:CNTB - Free Report) - Stock analysts at Leerink Partnrs issued their FY2028 earnings per share estimates for Connect Biopharma in a report released on Monday, February 5th. Leerink Partnrs analyst T. Smith forecasts that the company will earn ($0.44) perFebruary 3, 2024 | marketbeat.comConnect Biopharma (NASDAQ:CNTB) Trading 4% Higher Connect Biopharma (NASDAQ:CNTB) Shares Up 4%January 29, 2024 | finance.yahoo.comWill Connect Biopharma Holdings (NASDAQ:CNTB) Spend Its Cash Wisely?December 15, 2023 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Connect Biopharma Holdings (CNTB) and Inspire Medical Systems (INSP)December 15, 2023 | seekingalpha.comCNTB Connect Biopharma Holdings LimitedDecember 12, 2023 | morningstar.comConnect Biopharma Holdings Ltd ADR CNTBDecember 12, 2023 | marketwatch.comConnect Biopharma Shares Jump on Positive Results for Asthma Treatment TrialDecember 12, 2023 | msn.comConnect Biopharma gains as asthma candidate succeeds in mid-stage trialDecember 12, 2023 | finance.yahoo.comConnect Biopharma Announces Positive Rademikibart Global Phase 2b Topline Results in Adult Patients with Moderate-to-Severe Persistent AsthmaDecember 11, 2023 | finance.yahoo.comConnect Biopharma to Announce Top-Line Data from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma on December 12, 2023November 30, 2023 | finance.yahoo.comStonegate Healthcare Partners Releases Report on Transformative Therapies for Pruritus ManagementNovember 28, 2023 | finance.yahoo.comIs Connect Biopharma Holdings (CNTB) Stock Outpacing Its Medical Peers This Year?November 21, 2023 | msn.comWhy Is Skin Disease-Focused Connect Biopharma Stock Lower Today?November 21, 2023 | msn.comConnect Biopharma stock rises on positive data from dermatitis mAbNovember 21, 2023 | finance.yahoo.comConnect Biopharma Announces Positive Long-Term Data from the China Pivotal Trial of Rademikibart in Patients with Moderate-to-Severe Atopic DermatitisNovember 21, 2023 | finance.yahoo.comConnect Biopharma and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater ChinaNovember 20, 2023 | finance.yahoo.comConnect Biopharma to Announce Long-Term Data from the China Pivotal Trial of Rademikibart in Patients with Moderate-to-Severe Atopic Dermatitis on November 21, 2023November 9, 2023 | finance.yahoo.comConnect Biopharma Holdings Limited's (NASDAQ:CNTB) largest shareholders are private equity firms with 41% ownership, insiders own 22%November 6, 2023 | finance.yahoo.comIs Connect Biopharma Holdings (CNTB) Outperforming Other Medical Stocks This Year?November 1, 2023 | msn.comConnect Biopharma Holdings Ltd - ADR (CNTB) Price Target Increased by 16.67% to 7.14October 30, 2023 | marketbeat.comTrading was temporarily halted for "CNTB" at 09:10 AM with a stated reason of "LULD pause."October 20, 2023 | finance.yahoo.comHas Connect Biopharma Holdings (CNTB) Outpaced Other Medical Stocks This Year?September 15, 2023 | finance.yahoo.comConnect Biopharma Holdings Limited Sponsored ADR (CNTB) Upgraded to Buy: What Does It Mean for the Stock?September 15, 2023 | seekingalpha.comConnect Biopharma GAAP EPS of -RMB 3.90September 14, 2023 | finanznachrichten.deConnect Biopharma Holdings Limited: Connect Biopharma Reports First Half 2023 Financial Results and Provides Business UpdateSeptember 12, 2023 | finanznachrichten.deConnect Biopharma Holdings Limited: Connect Biopharma Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price RequirementAugust 24, 2023 | finance.yahoo.comConnect Biopharma to Participate in Upcoming September Investor ConferencesJuly 10, 2023 | finance.yahoo.comConnect Biopharma Presented Additional Data from its Atopic Dermatitis Pivotal Trial in China at the 2023 World Congress of Dermatology Get Connect Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CNTB and its competitors with MarketBeat's FREE daily newsletter. Email Address HUGE BUY ALERT: Move Fast, Musk... (Ad)I recently traveled to Phoenix, Arizona...And based on what I saw out there, I'm prepared to put my reputation on the line. Since 2018, my investment recommendations have averaged 115% per year. But one investment I've just discovered could blow them all away. You won't believe what I saw in Phoenix. CNTB Media Mentions By Week CNTB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CNTB News Sentiment▼1.190.57▲Average Medical News Sentiment CNTB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CNTB Articles This Week▼31▲CNTB Articles Average Week Get Connect Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CNTB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CRVS News Today JAGX News Today HOOK News Today MRNS News Today LFVN News Today BTAI News Today TPST News Today VACC News Today AFMD News Today BRNS News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CNTB) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperDid Intel Just Dethrone Nvidia?Chaikin AnalyticsAmerica’s worst nightmare?Porter & CompanyElon’s New Device is About to Shock the WorldInvestorPlaceClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsCharles Payne Demystifies OptionsUnstoppable ProsperityInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Connect Biopharma Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
